The National Institute for Health and Care Excellence (NICE) Guidance on Bladder Cancer; a Step in the Right Direction?

被引：8
|
作者：
Trainor, S. [1 ]
Choudhury, A. [2 ,3 ]
Huddart, R. [4 ,5 ]
Kiltie, A. E. [6 ]
Kockelbergh, R. [7 ]
Turner, W. [8 ]
Birtle, A. [9 ]
Crabb, S. J. [10 ]
机构：
[1] St Jamess Inst Oncol, Dept Med Oncol, Leeds, W Yorkshire, England
[2] Univ Manchester, Christie NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England
[3] Univ Manchester, Manchester Canc Res Ctr, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England
[4] Inst Canc Res, Sutton, Surrey, England
[5] Royal Marsden NHS Fdn Trust, Sutton, Surrey, England
[6] Univ Oxford, CRUK, MRC, Oxford Inst Radiat Oncol, Oxford, England
[7] Univ Hosp Leicester, Dept Urol, Leicester, Leics, England
[8] Cambridge Univ Hosp NHS Fdn Trust, Dept Urol, Cambridge, England
[9] Royal Preston Hosp, Rosemere Canc Ctr, Preston, Lancs, England
[10] Univ Southampton, Canc Sci Unit, Southampton, Hants, England
来源：
CLINICAL ONCOLOGY | 2017年 / 29卷 / 06期
关键词：
PERIOPERATIVE CHEMOTHERAPY; PATIENT EXPERIENCE; CARCINOMA; VINFLUNINE; CYSTECTOMY; PLUS;
D O I：
10.1016/j.clon.2017.01.040
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：344 / 347
页数：4
相关论文
共 50 条
  • [31] REVIEW OF POSSIBLE CAUSES OF VARIATION IN NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (NICE) TECHNOLOGY APPRAISALS
    Ling, C.
    Nuabor, W.
    Lyall, M.
    Stevenson, A.
    [J]. VALUE IN HEALTH, 2018, 21 : S200 - S200
  • [32] National Institute for Health and Care Excellence (NICE) acne guideline: what's the latest for dermatologists?
    Layton, A. M.
    McDonald, B. S.
    Mustapa, M. F. Mohd
    Levell, N. J.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (03) : 426 - 428
  • [33] REVIEW OF POSSIBLE CAUSES OF VARIATION IN NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (NICE) TECHNOLOGY APPRAISALS
    Ling, C.
    Nuabor, W.
    Lyall, M.
    Stevenson, A.
    [J]. VALUE IN HEALTH, 2018, 21 : S200 - S200
  • [34] VALIDATION OF THE NATIONAL INSTITUTE OF HEALTH AND CARE EXCELLENCE (NICE) CLINICAL CRITERIA FOR THE DIAGNOSIS OF KNEE OSTEOARTHRITIS
    King, Lauren
    Stanaitis, Ian
    Hung, Vivian
    Koppikar, Sahil
    Waugh, Esther
    Lipscombe, Lorraine
    Hawker, Gillian
    [J]. OSTEOARTHRITIS AND CARTILAGE, 2024, 32 : S212 - S212
  • [35] MANAGED ACCESS AGREEMENTS (MAAS) IN APPRAISALS CONDUCTED BY THE NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (NICE)
    Balman, E.
    Marshall, J. D.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A704 - A704
  • [36] Public Health at National Institute for Health and Clinical Excellence (NICE) from 2012
    Kelly, Michael P.
    [J]. PERSPECTIVES IN PUBLIC HEALTH, 2012, 132 (03) : 111 - 113
  • [37] Microbiological aspects of the UK National Institute for Health and Clinical Excellence (NICE) guidance on urinary tract infection in children
    Price, E.
    Pallett, A.
    Gilbert, R. D.
    Williams, C.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (05) : 836 - 841
  • [38] General application of the National Institute for Health and Clinical Excellence (NICE) guidance for active surveillance for men with prostate cancer is not appropriate in unscreened populations
    Wong, Lih-Ming
    Johnston, Richard
    Sharma, Naomi
    Shah, Nimish C.
    Warren, Anne Y.
    Neal, David E.
    [J]. BJU INTERNATIONAL, 2012, 110 (01) : 24 - 27
  • [39] Benchmarking Excellence: Evaluating Advanced Breast Carcinoma Care in Pakistan's Largest Cancer Hospital Against the National Institute for Health and Care Excellence (NICE) Guidelines
    Kanwal, Muhammad Awais
    Khalid, Umaisa
    Amir, Momina
    Sajjad, Barka
    Zeeshan, Rana
    Urooj, Namra
    Farooqi, Nifasat
    Parvaiz, Muhammad Asad
    Khan, Amina Iqbal
    Chaudhry, Mohammad Zulqarnain
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (08)
  • [40] National Institute for Clinical Excellence guidance: too NICE to glycoprotein IIb/IIIa inhibitors?
    Knight, CJ
    [J]. HEART, 2001, 85 (05) : 481 - 483
12345